Ropivacaine

Category: Anesthetic



Ropivacaine Overview

Ropivacaine (rINN) /ropvken/ is a local anaesthetic drug belonging to the amino amide group. The name ropivacaine refers to both the racemate and the marketed S-enantiomer. Ropivacaine hydrochloride is commonly marketed by AstraZeneca under the trade name Naropin. Contents 1 History 2 Clinical use 2.1 Contraindications 2.2 Adverse effects 2.3 Postarthroscopic glenohumeral chondrolysis 2.4 Treatment of overdose 3 References 4 External links History Ropivacaine was developed after bup...

Read more Ropivacaine Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ropivacaine

Recent Ropivacaine Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Ropivacaine
  • Injection: 0.2%, 0.5%, 0.75%, 1%, 10mg/ml, 2mg/ml, 5mg/ml, 7.5mg/ml
  • Solution: 100mg/10ml (10mg/ml), 100mg/20ml (5mg/ml), 150mg/20ml (7.5mg/ml), 150mg/30ml (5mg/ml), 1gm/200ml (5mg/ml), 200mg/100ml (2mg/ml), 200mg/20ml (10mg/ml), 20mg/10ml (2mg/ml), 400mg/200ml (2mg/ml), 40mg/20ml (2mg/ml), 500mg/100ml (5mg/ml), 50mg/10ml (5mg/ml), 75mg/10ml (7.5mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Ropivacaine: (43 results)

Showing the first 20, Sorted by National Drug Code
  • 0143-9263 Ropivacaine Hydrochloride 2 mg/ml Epidural; Infiltration Injection by Hikma Pharmaceuticals USA Inc.
  • 0143-9264 Ropivacaine Hydrochloride 5 mg/ml Epidural; Infiltration Injection by Hikma Pharmaceuticals USA Inc.
  • 0143-9265 Ropivacaine Hydrochloride 7.5 mg/ml Epidural Injection by Hikma Pharmaceuticals USA Inc.
  • 0143-9266 Ropivacaine Hydrochloride 10 mg/ml Epidural Injection by Hikma Pharmaceuticals USA Inc.
  • 0409-9300 Ropivacaine Hydrochloride 2 mg/ml Epidural; Infiltration Injection, Solution by Hospira, Inc.
  • 0409-9301 Ropivacaine Hydrochloride 5 mg/ml Epidural; Infiltration Injection, Solution by Hospira, Inc.
  • 0409-9302 Ropivacaine Hydrochloride 7.5 mg/ml Epidural; Infiltration Injection, Solution by Hospira, Inc.
  • 0409-9303 Ropivacaine Hydrochloride 10 mg/ml Epidural Injection, Solution by Hospira, Inc.
  • 0781-3140 Ropivacaine Hydrochloride 5 mg/ml Parenteral Injection, Solution by Sandoz Inc
  • 0781-3142 Ropivacaine Hydrochloride 10 mg/ml Parenteral Injection, Solution by Sandoz Inc
  • 17478-081 Ropivacaine Hydrochloride 5 mg/ml Epidural; Infiltration; Perineural Injection, Solution by Akorn, Inc.
  • 17478-082 Ropivacaine Hydrochloride 2 mg/ml Epidural; Infiltration; Perineural Injection, Solution by Akorn, Inc.
  • 25021-652 Ropivacaine Hydrochloride 5 mg/ml Epidural; Infiltration; Perineural Injection, Solution by Sagent Pharmaceuticals
  • 25021-653 Ropivacaine Hydrochloride 10 mg/ml Epidural Injection, Solution by Sagent Pharmaceuticals
  • 25021-654 Ropivacaine Hydrochloride 7.5 mg/ml Epidural; Perineural Injection, Solution by Sagent Pharmaceuticals
  • 25021-671 Ropivacaine Hydrochloride 2 mg/ml Epidural; Infiltration; Perineural Injection, Solution by Sagent Pharmaceuticals
  • 43066-015 Ropivacaine Hydrochloride 2 mg/ml Epidural; Infiltration; Perineural Injection by Baxter Healthcare Corporation
  • 43066-019 Ropivacaine Hydrochloride 5 mg/ml Epidural; Infiltration; Perineural Injection by Baxter Healthcare Corporation
  • 43066-023 Ropivacaine Hydrochloride 5 mg/ml Epidural; Infiltration; Perineural Injection by Baxter Healthcare Corporation
  • 43066-027 Ropivacaine Hydrochloride 10 mg/ml Epidural; Infiltration; Perineural Injection by Baxter Healthcare Corporation
  • 23 more results ...

Other drugs which contain Ropivacaine or a similar ingredient: (1 result)

Related Ropivacaine Topics:

Ropivacaine
first spinal use of ropivacaine ## Ropivacaine is a local anesthetic, it may cause side effects, such as nausea, headach... 1 reply




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 26 November 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA